Emerging Technology: Page 2

Alzheimer's panel validated in University of Pittsburgh study
By LabPulse.com staff writers
A team at the University of Pittsburgh has validated a new blood test panel that can simultaneously measure over 100 Alzheimer's disease biomarkers.
November 4, 2024
Alzheimers Tau Tangles Social
Molecular You partners with Calif. reference lab for biomarker testing
By LabPulse.com staff writers
Multiomic test developer Molecular You and reference laboratory HealthQuest Esoterics have partnered to expand predictive biomarker testing to healthcare clinics across the U.S.
October 21, 2024
Blood Test Samples Lab (1)
Flatiron, Myriad partner to integrate cancer test with EMR platform
By LabPulse.com staff writers
Myriad Genetics and Flatiron Health are partnering to integrate Myriad's MyRisk Hereditary Cancer Test into Flatiron's cloud-based OncoEMR electronic medical record (EMR) platform.
October 15, 2024
Computer Digital Cockpit Social
FDA approves Genentech's breast cancer therapy, Foundation Medicine's CDx
By LabPulse.com staff writers
The U.S. Food and Drug Administration (FDA) approved the FoundationOne Liquid test as a companion diagnostic (CDx) with Genentech's Itovebi combination therapy for certain patients with HR-positive, HER2-negative advanced or metastatic breast cancer.
October 14, 2024
Fda Sign Dc Social
MiLaboratories raises $10M in series A funding, launches NGS software platform
By LabPulse.com staff writers
Bioinformatics firm MiLaboratories closed a $10 million series A funding round alongside the launch of its Platforma.bio Software Development Kit.
October 11, 2024
Dna Data Ai Social
FDA greenlights first non-EUA at-home flu and COVID-19 test
By LabPulse.com staff writers
Healgen Scientific's test targets proteins from both SARS-CoV-2 and flu A and B, plus updated FDA test listings.
October 8, 2024
Influenza B virus particles, colorized blue, via National Institute of Allergy and Infectious Diseases (NIAID).
NowDiagnostics at-home syphilis test gets boost from Labcorp agreement
By LabPulse.com staff writers
STI National Strategic Plan aims to reverse recent rise of STIs.
October 10, 2024
Syphilis Treponema Bacteria Social
Owlstone, FDA's OSEL partner to develop VOC ID methods
By LabPulse.com staff writers
Owlstone Medical entered a research collaboration agreement with the FDA's Center for Devices and Radiological Health Office of Science and Engineering Laboratories (OSEL) to develop methods of identifying volatile organic compounds (VOCs) in breath.
September 30, 2024
Molecule Social
Pathologists detect microplastics in human brain tissue
By Will Morton
Pathologists have detected microplastics in the olfactory bulb brain tissues of eight deceased individuals in Sao Paulo, highlighting the need for further research about their effects on human health, reports a study published in JAMA Network Open.
September 25, 2024
Olfactory Bulb Brain Cr Social
Rapid diagnostic test developed for ALS
By LabPulse.com staff writers
A blood diagnostic test for amyotrophic lateral sclerosis (ALS) has been developed that can rapidly distinguish ALS from conditions that mimic ALS in its early stages with a high level of specificity and sensitivity.
September 13, 2024
Nerve Neuron Axon Social
FDA approves Illumina IVD kit as CDx
By LabPulse.com staff writers
The U.S. Food and Drug Administration (FDA) has approved Illumina's TruSight Oncology Comprehensive cancer biomarker IVD kit for use as a companion diagnostic to match patients to two targeted therapies, Bayer's Vitrakvi and Lilly's Retevmo.
August 27, 2024
Regulatory File Submit Social
Danaher acquires Genedata
By LabPulse.com staff writers
The Basel, Switzerland-based Genedata, which develops software for biopharmaceutical and biotech R&D, said that it is joining Danaher's life sciences segment.
August 19, 2024
Business Handshake Intelligence Social
Previous Page
Page 2 of 54
Next Page